Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Canadian clearance for first-in-man study of PPL-100 for drug-resistant HIV

Dec. 13, 2005

MK-0518: An effective short-term therapy in HIV-1 patients

Dec. 12, 2005

PK and tolerability profile of darunavir/low-dose ritonavir in humans

Dec. 12, 2005

Wyeth awarded new contract for development of therapeutic HIV vaccines

Dec. 7, 2005

PRO-140 enters phase Ib study in HIV

Dec. 5, 2005

Tibotec discontinues study of TMC-125 in protease inhibitor-naive patients

Dec. 2, 2005

Pfizer patents disclose compounds with potential for HIV and AIDS

Dec. 1, 2005

XACT trial of AMD-070 now enrolling HIV patients

Dec. 1, 2005

GSK and Institut Pasteur collaborate to develop AIDS vaccine

Nov. 30, 2005

CCR5 antagonist maraviroc useful as short-term monotherapy for HIV-1 infection

Nov. 28, 2005

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...